AR and prostate carcinoma: For instance, activated AR leads to a 50–450% increased glucose uptake in prostate cancer cells [82,83,84] as it can induce the level of several genes encoding glucose transporters such as SLC2A1, SLC2A3, SLC2A10, and SLC2A12 [82,85], and glycolytic genes such as HK1, HK2, PFK, PFKP, PFKFB2, and ENO1 [82,83,84].